<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cervical cancer screening &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cervical-cancer-screening/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 01 Jan 2026 15:29:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>cervical cancer screening &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Assessing HPV Self-Collection Readiness in Tamil Nadu</title>
		<link>https://bioengineer.org/assessing-hpv-self-collection-readiness-in-tamil-nadu/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 01 Jan 2026 15:28:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cervical cancer screening]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket: **HPV self-collection readiness]]></category>
		<category><![CDATA[mixed methods research]]></category>
		<category><![CDATA[Tamil Nadu healthcare study]]></category>
		<category><![CDATA[women's health barriers** **Açıklama:** 1. **HPV self-collection readiness:** Makalenin ana konusunu doğrudan belirtir (Tamil Nadu'da HPV kendi kendine örnekleme için hazırbulunuşluk). 2]]></category>
		<guid isPermaLink="false">https://bioengineer.org/assessing-hpv-self-collection-readiness-in-tamil-nadu/</guid>

					<description><![CDATA[In the ever-evolving landscape of healthcare, the importance of screening methods for cervical cancer has gained heightened attention. Studies around the world are focusing on innovative strategies to enhance early detection and streamline the processes involved in screening. One such examination arises from Tamil Nadu, India, where researchers have scrutinized the transition from Visual Inspection [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">312788</post-id>	</item>
		<item>
		<title>Self-Collected HPV Tests Match Clinician Samples for Cervical Cancer</title>
		<link>https://bioengineer.org/self-collected-hpv-tests-match-clinician-samples-for-cervical-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 09 Oct 2025 04:17:28 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cervical cancer screening]]></category>
		<category><![CDATA[Early cancer detection]]></category>
		<category><![CDATA[healthcare accessibility]]></category>
		<category><![CDATA[HPV self-collection]]></category>
		<category><![CDATA[Women's health empowerment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/self-collected-hpv-tests-match-clinician-samples-for-cervical-cancer/</guid>

					<description><![CDATA[In the landscape of cervical cancer screening, a groundbreaking study has emerged shedding light on the efficacy of self-collected human papillomavirus (HPV) samples, which presents a strong alternative to the traditional clinician-collected samples. Researchers, led by Ruben, Narasimhan, and Nolan, have conducted an innovative examination aiming not only to revolutionize cervical cancer screening methodologies but [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">277891</post-id>	</item>
		<item>
		<title>Exploring Home-based HPV Self-Sampling Acceptance in Cameroon</title>
		<link>https://bioengineer.org/exploring-home-based-hpv-self-sampling-acceptance-in-cameroon/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 05 Oct 2025 18:39:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cameroon]]></category>
		<category><![CDATA[cervical cancer screening]]></category>
		<category><![CDATA[home-based testing]]></category>
		<category><![CDATA[HPV self-sampling]]></category>
		<category><![CDATA[low-resource healthcare]]></category>
		<category><![CDATA[women's health]]></category>
		<category><![CDATA[women's health in Cameroon]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-home-based-hpv-self-sampling-acceptance-in-cameroon/</guid>

					<description><![CDATA[In a significant advancement for cervical cancer screening, a recent study published in BMC Health Services Research explores the acceptability of home-based HPV self-sampling among users and healthcare providers in the West region of Cameroon. This research highlights a pivotal shift in how cervical cancer screening can be made more accessible, especially in low-resource settings [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">276076</post-id>	</item>
		<item>
		<title>Advanced Cervical Lesion Detection via SEResNet101+SE-VGG19</title>
		<link>https://bioengineer.org/advanced-cervical-lesion-detection-via-seresnet101se-vgg19/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 28 May 2025 21:11:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cervical cancer screening]]></category>
		<category><![CDATA[colposcopy image analysis]]></category>
		<category><![CDATA[deep learning in medical imaging]]></category>
		<category><![CDATA[sensitivity-specificity in diagnostics]]></category>
		<category><![CDATA[SEResNet101 and SE-VGG19 models]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advanced-cervical-lesion-detection-via-seresnet101se-vgg19/</guid>

					<description><![CDATA[In a groundbreaking advancement poised to reshape cervical cancer screening and diagnosis, researchers have developed and evaluated two state-of-the-art deep learning frameworks—SEResNet101 and SE-VGG19—designed to drastically enhance the detection and classification of cervical lesions. Given the persistent global burden of cervical cancer, the imperative for more sensitive and specific diagnostic tools has never been more [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">247146</post-id>	</item>
	</channel>
</rss>
